125 related articles for article (PubMed ID: 16998464)
1. Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma.
Kuo KT; Liang CW; Hsiao CH; Lin CH; Chen CA; Sheu BC; Lin MC
Mod Pathol; 2006 Dec; 19(12):1570-7. PubMed ID: 16998464
[TBL] [Abstract][Full Text] [Related]
2. Cervical Carcinomas With Neuroendocrine Differentiation: A Report of 28 Cases With Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin With Coexisting Squamous and Adenocarcinomas.
Emerson RE; Michael H; Wang M; Zhang S; Roth LM; Cheng L
Int J Gynecol Pathol; 2016 Jul; 35(4):372-84. PubMed ID: 26630233
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
4. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression.
Strobeck MW; DeCristofaro MF; Banine F; Weissman BE; Sherman LS; Knudsen ES
J Biol Chem; 2001 Mar; 276(12):9273-8. PubMed ID: 11108719
[TBL] [Abstract][Full Text] [Related]
5. Expression of p21Cip1/Waf1 and p27Kip1 in small cell neuroendocrine carcinoma of the uterine cervix.
Kataoka TR; Tsukamoto Y; Matsumura M; Miyake A; Kamiura S; Ishiguro S; Nishizawa Y
Int J Surg Pathol; 2008 Jan; 16(1):11-5. PubMed ID: 18203777
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
9. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
10. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
11. CD44 expression in sinonasal inverted papillomas and associated squamous cell carcinoma.
Ingle R; Jennings TA; Goodman ML; Pilch BZ; Bergman S; Ross JS
Am J Clin Pathol; 1998 Mar; 109(3):309-14. PubMed ID: 9495203
[TBL] [Abstract][Full Text] [Related]
12. L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas.
Mancusi de Carvalho JP; Salim RC; Carvalho FM; Nogueira Dias Genta ML; Baracat EC; Carvalho JP
J Clin Pathol; 2020 Nov; 73(11):748-753. PubMed ID: 32366597
[TBL] [Abstract][Full Text] [Related]
13. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
14. CD44 is a marker of endocervical neoplasia.
Ibrahim EM; Blackett AD; Tidy JA; Wells M
Int J Gynecol Pathol; 1999 Apr; 18(2):101-8. PubMed ID: 10202665
[TBL] [Abstract][Full Text] [Related]
15. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
[TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
Cimic A; Vranic S; Arguello D; Contreras E; Gatalica Z; Swensen J
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):299-304. PubMed ID: 33208671
[TBL] [Abstract][Full Text] [Related]
17. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
[TBL] [Abstract][Full Text] [Related]
18. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
[TBL] [Abstract][Full Text] [Related]
19. Differences in the ARID-1 alpha expressions in squamous and adenosquamous carcinomas of uterine cervix.
Solakoglu Kahraman D; Diniz G; Sayhan S; Ayaz D; Uncel M; Karadeniz T; Akman T; Ozdemir A
APMIS; 2015 Oct; 123(10):847-50. PubMed ID: 26303865
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapy.
Bohr Mordhorst L; Ahlin C; Sorbe B
Gynecol Oncol; 2014 Nov; 135(2):305-11. PubMed ID: 25158038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
